Lasmiditan: Its Development and Potential Use
- PMID: 32026545
- DOI: 10.1002/cpdd.781
Lasmiditan: Its Development and Potential Use
Keywords: 5HT1f; cardiovascular; lasmiditan; migraine; triptan.
References
-
- WHO. World Health Report 2001. Geneva, Switzerland: World Health Organization; 2001.
-
- Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S. Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev. 2017;97:553-622.
-
- Lanfumey L, Hamon M, 5-HT1 receptors. Curr Drug Targets CNS Neurol Disord. 2004;3(1):1-10.
-
- Adham N, Bard JA, Zgombick JM, et al. Cloning and characterization of the guinea pig 5-HT1F receptor subtype: a comparison of the pharmacological profile to the human species homolog. Neuropharmacology. 1997;36:569-576.
-
- Goldstein DJ, Roon KI, Offen WW, et al. Selective serotonin 1F (5-HT1F) receptor agonist LY334370 for acute migraine: a randomized controlled trial. Lancet. 2001;358:1230-1234.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
